GlaxoSmithKline plc news

   Watch this stock
Showing stories 1 - 10 of about 169   

Articles published

GSK 1,319.50 +24.50 (1.89%)
price chart
Why Now Is The Perfect Time For Me To Buy GlaxoSmithKline plc And Dechra ...
As such, shares in GlaxoSmithKline (LSE: GSK) and Dechra (LSE: DPH) have held up better than the wider index during the last month, with them being down by 5% each versus almost 8% for the FTSE 100.
Should Gilead Sciences, Inc. Fear GlaxoSmithKline plc (ADR)?
Gilead Sciences, Inc. (NASDAQ:GILD) and GlaxoSmithKline plc (ADR) (NYSE:GSK) seem to be battling for a larger share of the HIV market.
How Safe Are These 5%-plus Yields? GlaxoSmithKline plc, HSBC Holdings plc ...
GlaxoSmithKline (LSE: GSK) currently yields 6.08%, an incredible return from one of the most solid UK dividend payers.
52-Week Low Stocks To Watch : GlaxoSmithKline PLC (ADR) (NYSE:GSK), Mindray ...
The following stocks (NYSE:GSK, NYSE:MR and NYSE:JOY) are close to 52-week low. For information, the 52-week low serves as an indicator for potential investors.
GlaxoSmithKline PLC Analyst Rating Update
Analysts at Zacks have given a short term rating of hold on GlaxoSmithKline PLC (NYSE:GSK) with a rank of 3. The shares have received an average rating of 2.63 from 8 brokerage firms.
Stock in Focus - GlaxoSmithKline PLC (NYSE:GSK)  Vanguard Tribune
Brokerages Set GlaxoSmithKline plc PT at $47.00 (NYSE:GSK)  Financial Wisdom Works
Drug Manufacturers Not to Miss - Heron Therapeutics, Inc. (NASD:HRTX ...
If you owned Pfizer stock when Viagra helped middle-aged men around the globe regain their mojo, you would have enjoyed a decent profit.
Better Dividend Stock: GlaxoSmithKline plc vs. AstraZeneca plc
While GlaxoSmithKline plc (NYSE: GSK) is more than twice as large as AstraZeneca plc (NYSE: AZN), the two pharmaceutical companies have a lot in common.
GlaxoSmithKline plc (ADR) (GSK) Stock Update - Takeover Rumors Drive Recent Gain  Bidness ETC
Is GlaxoSmithKline plc's Dividend Safe?  The Motley Fool UK
5 Things GlaxoSmithKline Plc Wants You to Know
Late last month U.K.-based pharmaceutical giant GlaxoSmithKline (NYSE: GSK ) reported its second-quarter results, and for a change they didn't cause investors to run for the hills.
Head To Head: Barclays plc vs GlaxoSmithKline plc
But if chosen well, your portfolio of shares could appreciate strongly once confidence returns to shares. The question is, what should you buy?
Why Growth Is Expected To Take Off At GlaxoSmithKline plc, Barclays PLC ...
Thanks to the effect of enduring patent losses across key labels, GlaxoSmithKline (LSE: GSK) is not expected to see the bottom line light up any time soon.